Obesity Clinical Trial
Official title:
Exercise Training in Pregnancy. Good for the Mother - Good for the Child?
Observational studies demonstrate that overweight in pregnancy is a risk factor for adverse
pregnancy outcomes as fetal macrosomia, prolonged labor, low Apgar score, shoulder dystocia,
nerve plexus injuries, increased proportion of instrumental deliveries and perineal ruptures.
There is a 2.6 fold risk for gestational diabetes mellitus (fourfold in morbidly obese women)
and a recent study has shown that fetuses of obese mothers develop insulin resistance in
uterus.
Main aims of this study are to assess if regular exercise in pregnancy among obese women can
prevent or influence weight gain; impaired cardiac function in mother and fetus/newborn;
impaired vascular function in mother; insulin resistance/sensitivity; body composition in
mother and offspring; lumbopelvic pain; urinary and/or fecal incontinence; prolonged labor
Women with a self-reported pre-pregnancy BMI of 28 or more will be eligible for our study.
Woman are eligible if they are 18 years or older, with a singleton live fetus at an early
(week 12-14) ultrasound scan. Exclusion criteria are pregnancy complications with high risk
for preterm labour or diseases that could interfere with participation.
Primary outcome measure is weight increase based on weight measured at 14 weeks and
immediately before labour. Assessments are done at baseline at 14 (12-18) weeks of pregnancy,
and again in week 38, as well as 3 months postpartum. Some measurements are also done at
other points in time. The maternal secondary outcome measurements include fasting glucose,
glucose tolerance assessed by 2-h, 75 mg per-oral glucose tolerance test, insulin resistance
assessed by HOMA-IR, weight, height, body composition estimated by skinfold measurements in
pregnancy and by dual energy x-ray absorptiometry postpartum, blood markers, lumbopelvic
pain, urin- and fecal incontinence, quality of life, psychological wellbeing, depression, and
diet.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |